Keshlata Cancer Hosp Stock Price Analysis and Quick Research Report. Is Keshlata Cancer Hosp an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Keshlata Cancer Hosp. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Keshlata Cancer Hosp has a PE ratio of 0 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Keshlata Cancer Hosp has ROA of 0.320150292929493% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Keshlata Cancer Hosp has a Current ratio of 8.16584360242517.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Keshlata Cancer Hosp has a ROE of 0.424141296544014%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Keshlata Cancer Hosp has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

• Sales growth: Keshlata Cancer Hosp has reported revenue growth of 5.99835318166286% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Keshlata Cancer Hosp for the current financial year is 5.93983247383704%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Keshlata Cancer Hosp is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Keshlata Cancer Hosp is Rs 0. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Keshlata Cancer Hosp in Ticker for free. Also, one can get the intrinsic value of Keshlata Cancer Hosp by using Valuation Calculators, which are available with a Finology ONE subscription. 

Keshlata Cancer Hosp FAQs

Q1. What is Keshlata Cancer Hosp share price today?
Ans: The current share price of Keshlata Cancer Hosp is Rs 0.

Q2. What is the market capitalisation of Keshlata Cancer Hosp?
Ans: Keshlata Cancer Hosp has a market capitalisation of Rs 0 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Keshlata Cancer Hosp?
Ans: The PE ratio of Keshlata Cancer Hosp is 0 and the P/B ratio of Keshlata Cancer Hosp is 0, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Keshlata Cancer Hosp share?
Ans: The 52-week high share price of Keshlata Cancer Hosp is Rs 0, and the 52-week low share price of Keshlata Cancer Hosp is Rs 0.

Q5. Does Keshlata Cancer Hosp pay dividends?
Ans: Currently, Keshlata Cancer Hosp does not pay dividends. Dividend yield of Keshlata Cancer Hosp is around 0%.

Q6. What are the face value and book value of Keshlata Cancer Hosp shares?
Ans: The face value of Keshlata Cancer Hosp shares is Rs 10, while the book value per share of Keshlata Cancer Hosp is around Rs 0. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Keshlata Cancer Hosp?
Ans: Keshlata Cancer Hosp has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Keshlata Cancer Hosp?
Ans: The ROE of Keshlata Cancer Hosp is 0.424141296544014% and ROCE of Keshlata Cancer Hosp is 0.274893803299095%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Keshlata Cancer Hosp a good buy for the long term?
Ans: The Keshlata Cancer Hosp long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Keshlata Cancer Hosp undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Keshlata Cancer Hosp appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Keshlata Cancer Hosp’s financials?
Ans: You can review Keshlata Cancer Hosp’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.